NEW YORK , Sept. 29, 2022 /PRNewswire/ -- The Urticaria Drugs Market report has been added to Technavio's offering. The urticaria drugs market value is anticipated to grow by USD 1.31 billion , at a CAGR of 10.35% during the forecast period. The urticaria drugs market report also offers information on several market vendors, including Allakos Inc., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bayer AG, F. Hoffmann La Roche Ltd., Genentech Inc., GlaxoSmithKline Plc, Johnson and Johnson, Meiji Holdings Co. Ltd., TerSera Therapeutics LLC, United BioPharma Inc., and Viatris Inc. among others. Request Free Sample Report.
One of the main factors boosting the market growth for urticaria medications is the rise in the prevalence of urticaria. A very common illness that leads to numerous medical consultations around the world is urticaria. The majority of patients receive inadequate care because of difficulties with medicine affordability and limited access to healthcare owing to social stigma, despite the fact that the prevalence is rising and is adversely affecting people's quality of life.
The prevalence of the disease rises as a result. Additionally, the rising prevalence of allergic diseases and infections is one of the main risk factors for urticaria around the world. Due to their severe immunosuppression, these patients develop hives when mast cells and histamines are released. Buy Sample Report.
The urticaria drugs market report provides complete insights on key vendors including Allakos Inc., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bayer AG, F. Hoffmann La Roche Ltd., Genentech Inc., GlaxoSmithKline Plc, Johnson and Johnson, Meiji Holdings Co. Ltd., Novartis AG, Otsuka Holdings Co. Ltd., Sanofi, TerSera Therapeutics LLC, Teva Pharmaceutical Industries Ltd., United BioPharma Inc., and Viatris Inc.
The competitive scenario provided in the urticaria drugs market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.
Amneal Pharmaceuticals Inc.: The company offers oleris which is a bio-based seven-carbon linear chain saturated fatty acid suitable for sustainable design.
Aurobindo Pharma Ltd.: The company offers sovermol range of green polyols has been specially designed for use in coating, adhesive, and putty applications.
F. Hoffmann La Roche Ltd.: The company offers BiOH polyols and polymers which are soy-based industrial ingredients for polyurethane products such as flexible foam used in upholstered furniture, mattresses, and others.
Genentech Inc.: The company offers castor polyol 115 which is used in coating, construction, plastics, adhesives, and sealants industries.
GlaxoSmithKline Plc: The company offers Cardyon which is a polyether carbonate polyol for coatings, adhesives, and sealants applications.
Find additional highlights on the growth strategies adopted by vendors and their product offerings, Download Free Sample Report.
Stem Cell Umbilical Cord Blood (UCB) Market by End-user and Geography - Forecast and Analysis 2022-2026: The stem cell umbilical cord blood (UCB) market share is expected to increase by $ 1.47 bn from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 16.87%.
Lennox-Gastaut Syndrome Treatment Market by Type and Geography - Forecast and Analysis 2022-2026: The Lennox-Gastaut Syndrome (LGS) treatment market share is expected to increase by USD 684.75 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.42%.
Accelerate at a CAGR of 10.35%
North America, Europe, Asia, and Rest of World (ROW)
US, Canada, Germany, UK, and China
Leading companies, competitive strategies, consumer engagement scope
Allakos Inc., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bayer AG, F. Hoffmann La Roche Ltd., Genentech Inc., GlaxoSmithKline Plc, Johnson and Johnson, Meiji Holdings Co. Ltd., Novartis AG, Otsuka Holdings Co. Ltd., Sanofi, TerSera Therapeutics LLC, Teva Pharmaceutical Industries Ltd., United BioPharma Inc., and Viatris Inc.
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
3.4 Market outlook: Forecast for 2021-2026
5.3 Acute urticaria - Market size and forecast 2021-2026
5.4 Chronic urticaria - Market size and forecast 2021-2026
7.3 North America - Market size and forecast 2021-2026
7.4 Europe - Market size and forecast 2021-2026
7.5 Asia - Market size and forecast 2021-2026
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
7.7 US - Market size and forecast 2021-2026
7.8 Germany - Market size and forecast 2021-2026
7.9 UK - Market size and forecast 2021-2026
7.10 China - Market size and forecast 2021-2026
7.11 Canada - Market size and forecast 2021-2026
8.3 Impact of drivers and challenges
10.4 F. Hoffmann La Roche Ltd.
11.3 Currency conversion rates for US$
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: media@technavio.com Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/usd-1-31-bn-growth-for-urticaria-drugs-market-through-2026-analysing-growth-for-pharmaceuticals---technavio-301635509.html
Musk's Twitter takeover is up in the air, but his leadership style represents many of the qualities the company's founder seems to admire.
ASML stock is down over 45% on the fear that there might be a decrease in semiconductor equipment spending.
Semiconductor stocks have tumbled in recent months amid flagging demand, with the S&P Semiconductors Select Industry Index dropping 36% year to date. Bank of America analysts recently discussed their favorite choices in the sector.
New research based on the life-cycle model says that people should strive for a consistent standard of living through their lives.
Why are people stealing these days? That’s a tough one. To some degree it’s a reflection of our times. Simply put, America’s social contract is straining.
Tesla deliveries in the third quarter will hit a record, but the EV giant has demand concerns in China. Tesla stock is below key levels.
From upstream activities to midstream, prospects for companies are rosy now, enhancing the outlook for the Zacks Oil & Gas US Integrated industry. COP, OXY, HES and WHD will make the most of the favorable business scenario.
(Bloomberg) -- Senior Biden administration officials pressed executives from some of the largest US gasoline producers to curtail overseas sales during a tense meeting Friday afternoon, suggesting that without voluntary action, the government could force the industry to stockpile more fuel in US tanks.Energy Secretary Jennifer Granholm and other administration officials chastised the industry representatives for low diesel stockpiles, floating the possibility of export limits and a requirement f
If Nike and VF are struggling into the fall, there are a host of others about to feel the pinch.
These top-tier companies are begging to be bought following a 34% peak decline in the Nasdaq Composite.
Some of the biggest telecommunications stocks just posted their steepest quarterly declines in two decades amid pressures new and old on the cable and wireless industries.
Life for the car manufacturers is becoming tougher as the economic slowdown worsens. Demand for cars is likely to sharply slow as consumers delay buying a new vehicles. "This is in keeping with our macroeconomic board's reduced forecast for 2.5% global GDP growth this year and 2.1% in 2023 ... on the back of substantial inflation, and higher interest rates meant to tame it," Moody's explained.
Social Security benefits can provide you with a stream of retirement income that is reliable. Deciding when to take benefits is an important question, especially if you're married and hope to qualify for spousal benefits. If you're already taking Social … Continue reading → The post Rules for Switching Social Security Benefits appeared first on SmartAsset Blog.
Investors were delighted to learn that an important source of revenue could be on its way to returning.
How much will you spend in retirement? This is a vital question to ponder as you approach your golden years. After all, a successful retirement plan not only focuses on the accumulation of money and assets, but also the sustainable … Continue reading → The post How Much Less You'll Spend Throughout Retirement Depends on These 2 Factors appeared first on SmartAsset Blog.
(Bloomberg) -- Most Read from BloombergMacKenzie Scott Files for Divorce From Science Teacher HusbandMeta to Cut Headcount for First Time, Slash Budgets Across TeamsTop Apple Executive Is Leaving After Making Crude Remarks in TikTok VideoMarjorie Taylor Greene’s Husband Files for Divorce After 27 YearsPutin Says Annexation Is Forever, Defends Ukraine Land GrabAmerican companies have had a growing list of reasons to downgrade their ties with China in recent years. Former President Donald Trump’s
Yahoo Finance's Akiko Fujita discusses Geely's purchase of Aston Martin stock.
Russian retail group IRG has unveiled plans for 65 new shops across 20 cities, to replace ones it used to run for Danish toy maker Lego, which exited the country in the wake of the Kremlin's invasion of Ukraine. Lego said in July it had terminated its contract with its franchisee IRG which owned and operated 81 stores on its behalf. IRG (Inventive Retail Group) said on Thursday its new stores would sell official Lego bricks "purchased through parallel imports and other suppliers" alongside other toys.
In the future, your choice of smartphone ecosystem—Android or iPhone—could determine which make and model of car you choose.